Last reviewed · How we verify
Mantle cell lymphoma
Approved treatments
- Imbruvica · AbbVie
Imbruvica works by blocking the activity of a specific enzyme called Bruton's tyrosine kinase (BTK), which is involved in the growth and survival of cancer cells. - Torisel · Pfizer
Torisel works by blocking the mTOR protein, which is involved in cell growth and division. - Fludara · Nihon Schering K.K.
Fludara works by interfering with the production of DNA and RNA in cancer cells, ultimately leading to cell death. - Calquence · AstraZeneca
Calquence works by blocking the activity of the BTK enzyme, which is essential for the activation and survival of B cells. - Revlimid · Bristol-Myers Squibb
Lenalidomide targets cereblon to degrade substrate proteins, inducing cytotoxicity and immunomodulation. - Velcade · University of Arkansas
- Velcade · Shilpa
Reversible inhibitor of 26S proteasome chymotrypsin-like activity preventing ubiquitinated protein degradation. - Imbruvica · Rabin Medical Center
- Calquence · iOMEDICO AG
- Brukinsa · Beigene Usa Inc
Brukinsa blocks the BTK protein, which is involved in the activation of B cells. - Fludarabin · Azienda Ospedaliera San Giovanni Battista
- Lenali · Singapore General Hospital
- Fludara · Celyad Oncology SA
- Revlimid · M.D. Anderson Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Mantle cell lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Mantle cell lymphoma treatment landscape brief
- Mantle cell lymphoma treatment updates RSS
Frequently asked questions about Mantle cell lymphoma
What drugs treat Mantle cell lymphoma?
Tracked treatments include Imbruvica, Torisel, Fludara, Calquence, Revlimid, Velcade, Brukinsa, Fludarabin.
What is the treatment for Mantle cell lymphoma?
Standard treatment for Mantle cell lymphoma includes Imbruvica, Torisel, Fludara, Calquence, Revlimid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Mantle cell lymphoma patent cliff · Mantle cell lymphoma CI report
- Treatment: Imbruvica · AbbVie
- Treatment: Torisel · Pfizer
- Treatment: Fludara · Nihon Schering K.K.
- Treatment: Calquence · AstraZeneca
- Treatment: Revlimid · Bristol-Myers Squibb
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing